But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
Because infants have developing immune and detoxification systems, the antioxidants provided through breast milk are quite beneficial
Licorice root is used for digestion and breathing problems, but it contains glycyrrhizin (a natural compound) that can lead to high blood pressure, low potassium, and kidney damage
Because peptide therapy may affect different body systems, medical evaluation and ongoing provider guidance are important before and during treatment